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Diabetes mellitusAbstract People with diabetes mellitus (DM) are at high risk of developing tuberculosis (TB) than
those without. People with diabetes are more likely to fail treatment and to die during treatment
compared to those without diabetes.
Aim of the work: The aim of the current study was to study the risk factors for pulmonary tuber-
culosis among diabetic patients in comparison to patients with DM alone.
Methods: 160 patients were grouped into two groups, the first group, 80 patients (DM-TB)
group, and the second group, 80 patients, diabetics with chest diseases other than TB. All patients
were subjected to meticulous history taking, clinical examination, radiological examination, and
laboratory investigations. All data were statistically analyzed.
Results: In this study the mean age of the DM-TB group was 52.90 ± 11.12 years and 54.57
± 9.84 years for DM group. There was no statistically significant difference in gender, smoking,
and DM treatment compliance between the two groups. There was a highly statistically significant
difference in body mass index (BMI), Hashish, Banjo and Tramadol addiction, poor glycemic
control, lower hemoglobin levels, platelet count, erythrocyte sedimentation rate and lower serum
protein and albumin. Bilateral affection was found in 45% and 21.5% in lower lobe in DM-TB.
Conclusion: From the current work it could be concluded that the factors determinant of pul-
monary tuberculosis among diabetics are weight loss, decreased BMI, drug addiction, uncontrolled
diabetes, higher rates of HbA1c, increased insulin requirements, anemia, higher ESR, higher plate-
let count and decreased serum proteins and albumin.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Tuberculosis is an infectious bacterial disease caused by
Mycobacterium tuberculosis, it is transmitted from person to
person via droplets from people with active respiratory disease
[10]. Approximately 9.4 million new cases and 1.7 million
deaths were encountered per year worldwide [23]. More than
818 N.H. Khalil, R.A. Ramadan350 million people have diabetes, prevalence is similar in both
low- and middle-income countries [32].
People with diabetes are at a higher risk of developing
tuberculosis (TB) than those without diabetes. The association
between diabetes and tuberculosis in developed countries was
around 2.5 times more likely to develop tuberculosis. These
findings were also true of developing regions where the preva-
lence of diabetes was twice as high in people with tuberculosis
than in people without tuberculosis [12].
Not only does diabetes contribute to a person’s risk of
developing tuberculosis, but it also makes it more difficult to
treat those who have both diseases. People with diabetes are
more likely to fail treatment and more likely to die during
treatment compared to those without diabetes [3].
Aim of the work
To study the risk factors for pulmonary tuberculosis among
diabetic patients in comparison to patients with DM alone.
Subjects and methods
This study was conducted on two groups of diabetic patients.
The first group (DM-TB group) was (80 patients) of newly
diagnosed active pulmonary tuberculosis and diabetes, while
the second group (DM group) was also (80 patients) of diabet-
ics with chest diseases other than TB. The two groups were
compared as regards factors determining the development of
pulmonary tuberculosis among diabetic patients.
Patients were considered to be diabetic if they had a previ-
ous history of DM and were receiving antidiabetic therapy or
were later found to have fasting plasma glucose P7.0 mmol/l
(126 mg/dl). Or with a glucose tolerance test, two hours after
the oral dose of plasma glucose 11.1 mmol/l (200 mg dl) [31].
Glycated hemoglobin (HbA1c) of greater than 6.5% is another
method of diagnosis, also random blood sugar of greater than
P11.1 mmol/l (200 mg/dl) in association with typical symp-
toms [31].
As regards (DM-TB) group: patients were considered
tuberculosis if at least two initial sputum smears positive for
AFB (acid fast bacilli); or one sputum examination positive
for AFB & radiographic abnormalities consistent with active
pulmonary tuberculosis; or one sputum positive for AFB &
culture positive for M.tuberculosis, and considered a new case
if patient has never had treatment for tuberculosis or who has
taken antituberculosis drugs for less than one month [31].
All patients were subjected to:
1- meticulous history taking with special attention to per-
sonal history (age, gender, cigarette smoking, drug
addiction, family history for TB and DM), history of
present illness, history of co-morbid diseases, and his-
tory of diabetes mellitus (type, duration, medication
and treatment compliance, and complications),
2- complete clinical examination,
3- radiological examination,
4- laboratory investigations (complete blood picture, ery-
throcyte sedimentation rate, fasting and post prandial
blood sugar, HbA1c, liver function tests, total proteins,
renal function tests, and sputum examination (direct
smear 3 sputum samples), HIV test (rapid test).Data were statistically analyzed (descriptive and analytical
statistics).
Results
The results are shown in Tables 1 – 18.
Discussion
The epidemic growth of DM especially occurs in developing
countries, where TB is highly endemic. As a result, DM and
TB will increasingly present together [24]. People with diabetes
are at higher risk of developing tuberculosis (TB) than those
without diabetes [32]. The present study is a two group study.
First group included 80 patients diagnosed as diabetes Mellitus
and Tuberculosis (DM-TB) group and the second group
included 80 patients diagnosed as diabetes only (with other
chest diseases rather than TB) from June of 2014 to May of
2015. All of them were admitted in Abbasia chest hospital.
All patients were subjected to full history, full clinical examina-
tion, routine laboratory investigation and chest X-ray.
As regards demographic data of the cases (Table 1), the
mean age of the DM-TB group was 52.90 ± 11.12 years, while
the mean age of DM group was 54.57 ± 9.84 years with p
value = .32, there was no statistically significant difference in
age between the two groups.
In the current study the mean age of (DM-TB) group was
around fifties. This matches the results of [22] who found that
DM-TB patients’ mean age was 53 years vs non-DM TB
patients 44 years (in his study on 581 patients in Mexico), sim-
ilarly [18] reported that the mean age of DM-TB patients was
51.5 years vs. 37.5 years in non-DM TB patients (in his study
on 1651 patients in Malaysia). DM-TB patients are usually
10–20 years older than TB patients without DM, as type 2
DM (which is more prevalent) is often associated with older
age.
It was noticed that there was male predominance in the cur-
rent study (Table 2). In DM-TB there were 56 males vs. 24
females and in DM group there were 55 males vs. 25 females
(p value = 0.86), so there was no statistically significant differ-
ence in gender between the two groups. A male predominance
in DM-TB group was also mentioned in the study by [18] in
Malaysia with 69.3% males among DM-TB patients, also
[27] in Saudi Arabia on 187 DM-TB patients and males repre-
sent 75.9% of the studied cases. The rate of TB is higher
among men than women, beginning in the young adult years
and persisting throughout life. This is a longstanding observa-
tion thought to reflect more frequent tuberculosis exposure in
the community among men than women [6].
Body mass index (BMI) was highly statistically significantly
different between the two groups (Table 3), as the mean BMI
in DM-TB group was 21.33 ± 4.14 kg/m2 vs. 26.62 ± 5.34 kg/m2
in DM group, and p value < 0.01. similarly, [1] reported that
the mean BMI of DM-TB patients was 21.1 kg/m2, also [19]
found that BM-TB patients’ mean BMI was 22.4 ± 4.9 kg/m2.
Lower BMI may be associated with anorexia and consumption
caused by tuberculosis infection.
In the current study, as shown in (Table 4), DM-TB group
had 33 smokers and 15 ex-smokers, while in DM group there
were 22 smokers and 25 ex-smokers. There was no statistically
significant difference in smoking between the two groups
Table 1 Distribution of studied cases as regards patient age.
Group N Mean SD± T test #p
Age
DM1 80 54.57 9.84 1.01 .32
DM-TB2 80 52.90 11.12
1 Diabetes group.
2 Diabetes and tuberculosis group.
Table 2 Distribution of studied cases as regards patient
gender.
Female Male Total Chi square #p
Gender
DM No. 25 55 80 0.3 0.86
% 31.25% 68.75% 100.0%
TB
DM
No. 24 56 80
% 30.0% 70.0% 100.0%
Total No. 49 111 160
% 30.6% 69.4% 100.0%
Table 3 Statistical analysis of weight, height and BMI of the
two groups.
Group N Mean SD± T test #p
Body mass index
Weight DM 80 74.13 14.39 6.61 <0.01
DM-TB 80 59.21 14.14
Height DM 80 166.12 12.73 0.02 0.43
DM-TB 80 166.08 6.67
BMI DM 80 26.62 5.34 6.10 <0.01
DM-TB 80 21.33 4.14
Table 5 History of addiction inhalation (Bonjo and Hashish).
Non Ex Current Total Chi
square
#p
Drug addiction (Banjo and Hashish)
DM No. 72 6 2 80 9.40 <0.01
% 90% 7.5% 2.5% 100%
Dm-TB No. 66 2 12 80
% 82.5% 2.5% 15% 100%
Total No. 138 8 14 160
% 86.25% 5% 8.75% 100%
Table 6 History of drug addiction: oral (Tramadol).
Non Ex Current Total Chi square #p
Oral addiction (Tramadol)
DM No. 73 5 2 80 7.18 0.02
% 91.25% 6.25% 2.50% 100%
DM-TB No. 70 1 9 80
% 87.50% 1.25% 11.25% 100%
Total No. 143 6 11 160
% 89.37% 3.75% 6.88% 100%
Study of risk factors for pulmonary tuberculosis 819(p value = 0.27), these results didn’t go with those of [16] who
stated that cigarette smoking confers a relative risk of about
1.5–2.0 for the development of tuberculosis. This, mechanism
could be explained as cigarette smoking activates alveolar
macrophages to produce a local inflammatory response, but
nicotine suppresses the antigen presentation function to
develop a specific immune response. Chronic exposure to
cigarette smoke reduces expression of surface proteins related
to antigen presentation by pulmonary macrophages [5]. Con-
flict in results may be interpreted as the study was conducted
in a chest hospital and DM group also had high prevalence
of smoking as about 34% of them were diagnosed as COPD.
As regards drug addiction between the two groups shown in
Tables 5–7, Hashish, Banjo (p value < 0.01) and TramadolTable 4 History of cigarette smoking among the two groups.
Non Ex
Smoking
DM No. 33 25
% 41.25% 31.25%
DM-TB No. 32 15
% 40.0% 18.75%
Total No. 65 40
% 40.6% 25.0(p value = 0.02) were statically significantly higher in
DM-TB group than DM group, on the other hand alcohol
(p value = 51) and IV addiction (p value = .08) were statisti-
cally insignificant. Empirical evidence and previous literature
suggested that epidemiologic factors associated with injection
and non-injection drug use (e.g., homelessness, incarceration,
poor nutrient) contribute to the high prevalence of TB among
drug users [8]. It may be not prevalent in alcohol and IV addic-
tion in our study due to the small number of cases, and lack of
their popularity or availability. Type II DM predominance was
noticed in the current study (Table 10), DM-TB group had 74
patients type II vs. 6 patients type I and DM group had 77
patients type II vs. 3 patients type I (p value = .3), so there
was no statistically significant difference in the type of diabetes
as a risk factor for tuberculosis.
This result matches the study by [14] in Iraq on 50 DM-TB
patients in which type II had a percentage of 84% compared to
16% type I. Only few studies specified whether TB patients
with DM had type I or type II DM, Type II DM is more
prevalent, but type I DM may be associated with a higher risk
of TB. [7] stated that there is a 26-fold risk of developing TB in
type I DM compared to 7-fold risk of developing TB among
type II DM (in his study in Ethiopia on 1352 DM patients).
This was not relevant in our study because of smaller sampleCurrent Total Chi square #p
22 80 1.2 0.27
27.50% 100%
33 80
41.25% 100%
55 160
34.4% 100.0%
Table 7 History of drug addiction (I.V. addiction).
Non Ex Current Total Chi
square
#p
I.V. addiction
DM No. 80 0 0 80 3.06 0.08
% 100% 00% 00% 100%
DM-TB No. 77 0 3 80
% 96.25% 00% 3.75% 100%
Total No. 157 0 3 160
% 98.12 00% 1.88% 100%
Table 8 History of alcohol intake between the two groups.
Non Ex Current Total Chi
square
#p
Alcohol intake
DM No. 78 1 1 80 1.33 0.51
% 97.5% 1.25% 1.25% 100%
DM-TB No. 78 0 2 80
% 97.5% 00% 2.5% 100%
Total No. 156 1 3 160
% 97.5 1.62 1.88% 100%
Table 9 History of tuberculosis close contact.
No Yes Total
DM No. 80 00 80
% 100% 00% 100%
DM-TB No. 80 00 80
% 80% 00% 100%
Total No. 160 00 160
% 100% 00% 100%
Table 10 Type of DM.
Type I Type II Total Chi square #p
Type of DM
DM No. 3 77 80 1.06 0.3
% 3.75% 96.25% 100%
DM-TB No. 6 74 80
% 7.5% 92.5% 100%
Total No. 9 151 160
% 5.6% 94.4% 100%
Table 11 Duration of diabetes among established cases- in
years- in the two groups.
Group N Range Mean SD± T test #p
Duration of diabetes among established cases (in years)
DM 66 1–20 6.04 4.92 1.1 0.27
DM-TB 62 1–30 7.08 5.67
Table 12 History of compliance for DM treatment (before
admission).
No Yes Total Chi square #p
DM No. 30 36 66 1.547 0.21
% 45.46% 54.54% 100.0%
DM-TB No. 35 27 62
% 56.45% 43.55% 100.0%
Total No. 65 63 128
% 50.95% 49.05% 100.0%
Table 13 History of repeated chest infections (LRTIs) among
the two groups.
No Yes Total Chi square #p
Repeated chest infections (LRTIs)
DM No. 53 27 80 15.6 <0.01
% 66.25% 33.75% 100%
DM-TB No. 28 52 80
% 35% 65% 100%
Total No. 81 79 160
% 50.60% 49.40% 100%
Table 14 Complete blood count.
Group Mean SD± T test #p
Complete blood count
Hemoglobin DM 12.58 2.05 4.45 <0.01
DM-TB 11.19 1.89
Platelet DM 270.88 104.65 4.41 <0.01
DM-TB 351 126.82
TLC DM 9.88 4.79 1.29 0.2
DM-TB 11.06 6.62
ESR DM 41.81 36.17 9.76 <0.01
DM-TB 93.77 30.95
820 N.H. Khalil, R.A. Ramadansize as type I diabetes represented only 5% of the whole stud-
ied cases.
Regarding the compliance for diabetes treatment before
admission in DM-TB group (62 patients) was 43.55%
compared to 54.54% in DM group (64 patients) and
(p value = .21) (Table 12). Though diabetes was less
controlled in group DM-TB than DM group, treatment com-
pliance was still statistically insignificant, this may be due to
that some patients’ blood sugar was not adjusted to treatment
yet they continue on the same line of treatment.
As regards laboratory investigation for diabetes in the cur-
rent study (Table 15) DM-TB group was 214 ± 67.43 mg/dlvs. DM group 153.53 ± 41.) 3 mg/dl (p value < .01). Post-
prandial blood glucose was 319 > 01 ± 85.01 mg/dl in
M-TB groups vs. 263.23 ± 73 > 88 mg/dl in DM groups
(p value < 0.01). HgA1c mean in DM-TB group was
9.88 m ± 2.03 mmo1/L vs. 7.89 ± 1.58 mmo1/L vs. 7.89
± 1.58 mmo1/L in DM group (p value < 0.01). These results
show a high statistical significance for poor glycemic control as
a risk factor for TB. These results match the study of [14] on 50
DM-TB patients in Iraq in which the mean fasting blood
glucose was 206.24 mg/d1 with SD ± 2.48, also the study by
[1] in Indonesia the mean fasting blood glucose level among
DM-TB was 215 (154–290)mg/d1.
Table 15 Comparison between the two groups as regards F.B.
S. and P.P.G. and HbA1c.
Group Mean SD± T test #p
Blood sugar lab investigation
FBG DM 153.53 41.03 6.88 <0.01
DM-TB 214.28 67.43
PPG DM 263.23 73.88 4.43 <0.01
DM-TB 319.01 85.01
HbA1c DM 7.89 1.58 6.90 <0.01
DM-TB 9.88 2.03
Table 16 Serum total protein and serum albumin.
Group Mean SD± T test #p
Serum proteins
FBG DM 7.03 0.73 3.80 <0.01
DM-TB 6.64 0.56
PPG DM 3.55 0.60 2.29 0.02
DM-TB 3.3 0.47
Table 17 H.I.V rapid test.
No Yes Total
H.I.V rapid test
DM No. 80 00 80
% 100% 00% 100%
DM-TB No. 80 00 80
% 80% 00% 100%
Total No. 160 00 160
% 100% 00% 100%
Table 18 X-ray site of lesion among DM-TB group.
Lung zone (s) No. Percent %
Right upper 15 18.75
Right middle 2 2.5
Right lower* 8 10
Whole right side 5 6.25
Left upper 3 3.75
Left lower 7 8.75
Whole left side 4 5.0
Bilateral basal* 2 2.5
Bilateral (multi labor) 34 42.5
Total 80 100.0
* Lower lobe involvement total was 21.25%.
Study of risk factors for pulmonary tuberculosis 821Also results demonstrated that repeated chest infections
(lower respiratory tract infections) LRTIs (Table 13) were
found to be significant risk factors for tuberculosis
(p value < 0.01). This could be interpreted as recurrent
infections reflect a state of decreased host immunity, as hyper-
glycemia results in protein glycation and formation of
advanced glycation end products (AGEs), which can have a
diverse impact on host cell function. It can cause impairment
of host proteins involved in complement activation, bacterialuptake, phagocytic killing, and change the binding of host
surface receptors for pathogens [9].
As regards complete blood count (Table 14), lower hemo-
globin levels were found to be highly statically significant in
DM-TB patients as mean hemoglobin was 11.19 ± 1.89 mg/d1
vs. 12.58 ± 2 > 5 mg/d1 in DM group and p value < 0.01.
Lee et al. [15] supported these results in his systematic review
he stated that anemia has been reported in 16%–94% in
patients with pulmonary TB, although a different definition
was applied. All chronic infections including TB can cause
anemia. Various pathogeneses have been suggested in
TB-associated anemia, but most studies have shown suppres-
sion of erythropoiesis by inflammatory mediators as a cause
of anemia. Nutritional deficiency and malabsorption
syndrome can deepen the severity of anemia. However, the
observation that patients with TB-associated anemia display
an absence of the bone marrow iron and the same red blood
cell distribution width as that observed with iron-deficiency
anemia, suggests that iron-deficiency is a possible cause of
anemia in patients with TB.
Platelet count (Table 14) was found to be highly statistically
significant in diabetic TB patients, mean platelet count in case
group was 351.91 ± 126.82  109/L versus mean platelet
count in control group was 270.88 ± 104 > 65 109/L and
(p value < 0.01). Similarly [4] in Sudan mean platelet count
was 344.0  109/L for TB patients vs. 248.2  109/L for non-
TB controls. As such [2] in the United States, 85 patients with
culture-confirmed M tuberculosis infection were compared
with 48 patients culture-negative. Thrombocytosis (platelet
count >360  109/L) was significantly more common in
patients with M tuberculosis (50% 0 than negative for
mycobacterium (4%), (p vale <+ .001). This could be
explained as mycobacterium tuberculosis infection associated
reactive thrombocytosis, as reactive thrombocytosis is found
in infectious diseases and is associated with significant elevation
of thrombopoietin especially during acute phase and fever [29].
Erythrocyte sedimentation rate (ESR) was found to be
highly statistically significant for tuberculosis in the current
study (Table 13), as in DM-TB group mean ESR was
93.77 ± 30 > 95 mm/h, while in DM group ESR was
41.81 ± 36 > 17 mm/h (p value < 0.01). Similarly [1]
reported that DM-TB patients’ mean ESR was 93 mm/h, also
Bashir et al. [4] reported that mean ESR among TB patients
was 115.17 mm/h vs. 11.08 mm/h in healthy controls
(p value < 0.01) (in his case–control study in Sudan). This
could be interpreted as that ESR is governed by the balance
between pro-sedimentation factors, mainly fibrinogen, and
those factors resisting sedimentation. When an inflammatory
process is present, the high proportion of fibrinogen in the
blood causes red blood cells to stick to each other. The red
cells form stacks called ‘rouleaux’ which settle faster, due to
their increased density, and one of the major causes of this
process is tuberculosis.
In the current study, lower total proteins in blood and lower
serum Albumin were associated with a higher statistically sig-
nificant risk for tuberculosis (Table 16). Mean serum total pro-
teins in DM-TB group was 6.64 ± .56 g/d1 vs. 7.03 ± .73 g/d1
in DM group and (p value < 0.01), and serum albumin in
DM-TB group was 3.35 ± .47 g/d1 and p value = .02.
These previous results reflect a state of malnutrition among
DM-TB patients. These results were supported by [13] who
stated that tuberculosis patients have been found to have a
822 N.H. Khalil, R.A. Ramadanlower serum albumen concentration than controls by 10% and
p value < 0.05 (in a case–control study on 82 patients). These
results go also with a study in Uganda by [25] who demon-
strated that poor nutritional status is common among adults
with pulmonary tuberculosis, as serum albumin was 3.23
±> 047 mg/d1. Tuberculosis is probably associated with
more severe malnutrition than other chronic illness. For any
infection, there is a complex interaction between the host
response and the virulence of the organisms, which modulates
the overall metabolic response and the degree and the pattern
of tissue loss. In patients with tuberculosis, Anorexia, nutrient
malabsorption, micronutrient malabsorption, and altered
metabolism lead to wasting [17]. HIV testing (Table 17) was
negative for all cases; taking in mind that Egypt is considered
a low-HIV-prevalence country with less than 1% of the popu-
lation estimated to be HIV-positive [28].
Concerning the radiological distribution of pulmonary
involvement (Table 18) in the current study, bilateral (multi-
labor) affection of both lung fields was found in 45% of cases.
Similarly, [14] documented that bilateral (multilabor) involve-
ment was 64% (in his study in Iraq on 50 DM-TB cases). On
the other hand results of one study of pulmonary TB, CT
findings by [11] showed a high prevalence of non segmental
distribution (30%) and multiple small cavities among
DM-TB patients. However, an unusual localization such as
lower lobe lesions, involvement of the anterior segment of
the upper lobes or right middle lobe, was similar between
DM-TB and non-DM TB cases. The current study demon-
strated also that lower lobe involvement was found in 21.5%
of DM-TB cases, similarly [26] stated that lower lobe involve-
ment in DM-TB patients was 23% vs. 2.4% in non-DM TB
patients (in his study on 692 TB patients in Saudi Arabia), also
[21], on 320 TB patients in Mexico stated lower lung zone
involvement was 29% in DM-TB vs. 3% in non-diabetics.
However, there were other studies that did not find any differ-
ence between DM and non DM cases like [30] who found that
lower lobe tuberculosis was 15.2% in DM-TB patients vs.
22.4% in non-diabetic TB patients (in his study on 461 patients
in Taiwan).
Generally speaking and from the available literature, there
have been conflicting findings regarding the effect of DM on
the radiologic characteristics of pulmonary tuberculosis. Dif-
ferences in radiological presentation were subjected to many
theories some have suggested this difference may be apparent
among uncontrolled DM cases (HbA1cP 7). Also, it has been
suggested that severe pulmonary involvement in DM patients
may actually be related to smoking status and not DM alone.
Also, differences in patient selection and the definition of DM
have to be considered when it comes to some of these discrep-
ancies between different studies [20].
Few studies have shown that the clinical characteristics of
TB do not differ among diabetics and non-diabetics. [27] found
in a comparative study in Saudi Arabia between DM-TB
patients and non-DM TB patients, cough 98.9% vs. 97.8%,
hemoptysis in 42.6% vs. 40.7% and toxemic manifestation
80.9% vs. 73.9% respectively. Also [1] found that DM-TB
patients had cough 98.8% of vs. 97.5% in non-DM TB
patients, hemoptysis 42.6% vs. 40.7% dyspnea 69.1% vs.
63.7% and toxemic manifestation 96.8% vs. 80.4%, also mean
duration of symptoms was 8 weeks (which are also close to our
results).Conclusion
From the current work it could be concluded that the factors
determinant of pulmonary tuberculosis among diabetics are
weight loss, decreased BMI, drug addiction, uncontrolled
diabetes, higher rates of HbA1c, anemia, higher ESR, higher
platelet count and decreased serum proteins and albumin.
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